Vimarsana
Biggest News Aggregation in the World

Khurram Jamil News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Khurram Jamil. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Khurram Jamil Today - Breaking & Trending Today

Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update - Vimarsana News

Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update

Published: March 29, 2024

29.03.2024 - NORCROSS, Ga., March 29, 2024 (GLOBE NEWSWIRE) - Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the year ended ...

Source: wallstreet-online.de
Related Topics:
Richard UihleinChris CalabreseJack CallicuttKhurram JamilKevin GardnerBenjamins CarsonPol BoudesCompany Annual Report On FormBelapectin ProgramDrug AdministrationCompany ContactExchange CommissionGalectin Therapeutics IncChief Medical OfficerFast Track DesignationData SafetyMonitoring BoardLiver MeetingAmerican AssociationLiver DiseasesAnnual ReportFast TrackPrivate Securities Litigation Reform ActChief FinancialRelations Contacts
Galectin Therapeutics : Reports 2023 Financial Results and Provides Business Update - Form 8-K -March 29, 2024 at 07:59 am EDT - Vimarsana News

Galectin Therapeutics : Reports 2023 Financial Results and Provides Business Update - Form 8-K -March 29, 2024 at 07:59 am EDT

Published: March 29, 2024

Galectin Therapeutics, Inc. , the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the year ended December 31,...

Source: marketscreener.com
Related Topics:
Khurram JamilChris CalabreseBenjamins CarsonJack CallicuttJoel LewisPol BoudesRichard UihleinKevin GardnerCompany Annual Report On FormExchange CommissionCompany ContactBelapectin ProgramDrug AdministrationGalectin Therapeutics IncGalectin Therapeutics ReportsProvides Business UpdateChief Executive OfficerGalectin TherapeuticsMetabolic Dysfunction Associated SteatohepatitisSafety Monitoring BoardChief Medical OfficerFast Track DesignationProgram HighlightsData SafetyMonitoring Board
Galectin Therapeutics Expands Clinical Team with the Appointment of Khurram Jamil, M.D. as Vice President, Clinical Development - Vimarsana News

Galectin Therapeutics Expands Clinical Team with the Appointment of Khurram Jamil, M.D. as Vice President, Clinical Development

Published: March 12, 2024

NORCROSS, Ga., March 12, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target ...

Source: businessinsider.com
Related Topics:
United StatesPolf BoudesChris CalabreseKhurram JamilJack CallicuttKevin GardnerCompany Annual Report On FormGalectin Therapeutics IncKing Edward Medical University At LahoreOrganon Pharmaceuticals United StatesClinical DevelopmentMallinckrodt PharmaceuticalsIkaria IncSeaton Hall UniversityCompany ContactDrug AdministrationVice PresidentChief MedicalNew Drug RegistrationVice President HepatologyNew England JournalGeneral SurgeryKing Edward Medical UniversityFast TrackPrivate Securities Litigation Reform Act
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2023 Scientific Meeting - Vimarsana News

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2023 Scientific Meeting

Published: November 1, 2023

/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKTQ), a global specialty pharmaceutical company, today announced that three scientific abstracts evaluating...

Source: prnewswire.com
Related Topics:
United StatesJuan Carlosq VelezPrnewswire MallinckrodtDerek BelzHanim WadeiJamilk TerlipressinDanielj SpecialeKhurram JamilMallinckrodt Hospital Products IncOchsner HealthGreen Room CommunicationsNational Organization For Rare DisordersMallinckrodt PharmaceuticalsExchange CommissionClinical Development Critical CareAmerican Society Of NephrologyPennsylvania Convention CenterAmerican SocietyKidney WeekImportant Safety InformationBoxed WarningJuan CarlosVice PresidentClinical DevelopmentSerum Creatinine
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American College of Gastroenterology (ACG) Annual Scientific Meeting - Vimarsana News

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American College of Gastroenterology (ACG) Annual Scientific Meeting

Published: October 22, 2023

/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKTQ), a global specialty pharmaceutical company, today announced that three posters detailing findings from...

Source: prnewswire.com
Related Topics:
United StatesBritish ColumbiaUnited KingdomPalo AltoRonaldj WongJacquelineg OlearyDerek BelzRobertj WongPrnewswire MallinckrodtPaulj ThuluvathRyan TaylorDanielj SpecialeKhurram JamilPrashant PandyaMallinckrodt PharmaceuticalsStanford University School Of MedicineGreen Room CommunicationsNational Organization For Rare DisordersClinical Development Critical CareMallinckrodt Hospital Products IncAmerican College Of GastroenterologyExchange CommissionUnited States Census BureauAmerican CollegeAnnual Scientific Meeting